3 July 2020 in Respiratory Research
Asthma is a complex heterogeneous disease. The neutrophilic subtypes of asthma are described as persistent, more severe and corticosteroid-resistant, with higher hospitalization and mortality rates, which seriously affect the lives of asthmatic patients. With the development of high-throughput sequencing technology, an increasing amount of evidence has shown that lower airway microbiome dysbiosis contributes to the exacerbation of asthma, especially neutrophilic asthma. NontypeableHaemophilus influenzaeis normally found in the upper respiratory tract of healthy adults and is one of the most common strains in the lower respiratory tract of neutrophilic asthma patients, in whom its presence is related to the occurrence of corticosteroid resistance. To understand the pathogenic mechanism by which nontypeableHaemophilus influenzaecolonization leads to the progression of neutrophilic asthma, we reviewed the previous literature on nontypeableHaemophilus influenzaecolonization and subsequent aggravation of neutrophilic asthma and corticosteroid resistance. We discussed nontypeableHaemophilus influenzaeas a potential therapeutic target to prevent the progression of neutrophilic asthma.